Upper gastrointestinal endoscopy for diagnosis of complications of regional hepatic chemotherapy.
Seven of 26 patients undergoing insertion of "Infusaid" perfusion pumps with hepatic artery catheters for regional hepatic perfusion with 5 fluorodeoxyuridine were diagnosed to have gastritis (n = 5) or penetrating duodenal ulcers with catheter exposure (n = 2). Diagnosis is best achieved by esophagogastroduodenoscopy. The ulcers required removal of the pumps and gastric resections. The gastritis responded only to cessation of drug infusion. These complications represent a significant risk to regional hepatic chemotherapy. Physicians caring for this group of patients will be unable to predict which individuals will suffer these complications when using preoperative or postoperative parameters such as age, sex, tumor type, arterial anatomy or flow patterns on nuclear isotope scanning. A high index of suspicion must be maintained during the critical third and fourth cycles of chemotherapy in all patients undergoing regional hepatic chemotherapy.
D000328:Adult; D000368:Aged; D004724:Endoscopy; D005260:Female; D005467:Floxuridine / Q000008:administration & dosage; D005767:Gastrointestinal Diseases / Q000139:chemically induced / Q000175:diagnosis*; D006499:Hepatic Artery; D006801:Humans; D007261:Infusions, Intra-Arterial / Q000009:adverse effects* / Q000295:instrumentation; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy
D005467:Floxuridine